KSpine Raises $2.5M for Spinal Implant to Treat Scoliosis

Minnesota medical device company KSpine raised $2.5 million that will fund clinical trials for the company's spinal implant to treat scoliosis, according to a Medcity News report.

The KSpine implant involves fewer screws that traditional scoliosis treatments and only one rod. CEO Fred W. Kornahrens. Longhini, co-founder of Voyageur Medical, an early stage investor in medical device companies, said KSpine has raised $16 million since its start in 2008.

Related Articles on Medical Devices:
Novus Scientific Receives New U.S. Patent for Mesh Implant
Study: Automated Suturing Lowers Operating Time, Cost
How Technology Has Changed the Medical Industry

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers